When it comes to R&D at Boehringer Ingelheim Vetmedica Kevin Fowler is a go to guy. He’s seen here showing research labs at the BIVI facilities in St. Joseph, MO to a group of ag media.
The first thing that excites Kevin after BIVI acquired some of the Ft. Dodge Animal Health business is the ability to expand more into the dog and cat vaccine lines of products. He says this is a perfect fit and gives the company a great opportunity for future growth.
At the St. Joseph site they have 80 acres of research, manufacturing and engineering services. They have similar facilities at the Ft. Dodge, IA site they just acquired but it’s much larger at 320 acres.
Kevin thinks that one of the things that sets BIVI apart from other companies when bringing a product to market is their R&D group which is very team-oriented. He’s working on a 10 year plan to grow and integrate in an organized manner.
You can listen to my interview with Kevin below.